Rapport Therapeutics
RAPP
#7348
Rank
$0.32 B
Marketcap
$8.99
Share price
5.52%
Change (1 day)
N/A
Change (1 year)

Rapport Therapeutics (RAPP) - Cash on Hand

Cash on Hand as of December 2024 : $0.30 Billion USD

According to Rapport Therapeutics's latest financial reports the company has $0.30 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Rapport Therapeutics - Cash on Hand chart (from 2023 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.30 B107%
2023-12-31$0.14 B373.31%
2022-12-31$31.15 M